Portugal (PT)

Assessment of occupational exposure to hexavalent chromium - recommendations from HBM4EU chromates study (2022) Santonen T, Bocca B, Bousoumah R, Duca RC, Galea KS, Godderis L, Göen T, et al. Conference contribution Towards developing a Core Outcome Set for malnutrition intervention studies in older adults: a scoping review to identify frequently used research outcomes (2022) Visser M, Mendonça N, Avgerinou C, Cederholm T, Cruz-Jentoft AJ, Goisser S, Kiesswetter E, et al. Journal article, Review article European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCAA and the EBSB working groups of the ESCD, and the GEIDACC (2022) Uter W, Wilkinson SM, Aerts O, Bauer A, Borrego L, Buhl T, Cooper SM, et al. Journal article Roadmap on Spin-Wave Computing (2022) Chumak AV, Kabos P, Wu M, Abert C, Adelmann C, Adeyeye A, Akerman J, et al. Journal article Economic applications of quantile regression 2.0 (2022) Fitzenberger B, Koenker R, Machado J, Melly B Journal article Osteogenic lithium-doped brushite cements for bone regeneration (2022) Hurle K, Maia FR, Ribeiro VP, Pina S, Oliveira JM, Götz-Neunhoeffer F, Reis RL Journal article The Attitudes of European Medical Students towards the Clinical Importance of Neuroanatomy (2022) Moxham BJ, Brenner E, Plaisant O, Pais D, Stabile I, Scholz M, Paulsen F, et al. Journal article Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study (2021) Bizjak M, Kosnik M, Dinevski D, Thomsen SF, Fomina D, Borzova E, Kulthanan K, et al. Journal article The impact of the Pliensbachian–Toarcian crisis on belemnite assemblages and size distribution (2021) de Baets K, Nätscher P, Rita P, Fara E, Neige P, Bardin J, Dera G, et al. Journal article, Original article Lu-177-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial (2021) Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, et al. Journal article